Share the Science: Reducing Risk of Infection in Cord Blood Transplantation - Dr. Amanda Olson

Save the Cord Foundation and WellSky are proud to welcome Dr. Amanda Olson from MD Anderson Cancer Center, as our featured speaker for our next edition of Share the Science on August 26th, 2021 2pm ET / 11am PT. Join us to hear Dr. Olson review and discuss an evidence-based approach to reducing the risk of infection in cord blood transplants. RECORDING NOW AVAILABLE.
​
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

What are the risks of cord blood transplantation?

Even the most successful medical procedures carry risks for the patient. Knowing how to manage those risks are key to giving your patients the best care possible and giving them the best odds possible for treatment.  

Join us to hear Dr. Amanda Olson speak from the University of Texas MD Anderson Cancer Center, in detail about the best practices in the prevention and treatment of opportunistic infections in adult patients undergoing cord blood transplantation. She will present evidence-based recommendations for the prevention and treatment of opportunistic infections in adult patients undergoing CBT.

Topics will include:

• Bacterial, fungal, viral, pneumocystis jirovcii and toxoplasmosis prophylaxis
• Suggested PCR (polymerase chain reaction) monitoring for viruses
• Therapy for the most commonly encountered infections after CBT

The webinar will review key concepts including the recent important role of letermovir in the prevention of CMV reactivation. In instances where there is a paucity of data, practice recommendations are provided, including the duration of antimicrobial prophylaxis.

SHARE THE SCIENCE
with

Amanda L. Olson, M.D.

Associate Professor, Department of Stem Cell Transplantation,
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
 
"Reducing Risk of Infection in Cord Blood Transplantation"

Free webinar.  Open to the public.
​
Thursday, August 26th at 2 pm ET / 11am PT

RECORDING NOW AVAILABLE

WATCH NOW- Share the Science: Dr. Amanda Olson - Cord Blood Transplantation

About the speaker

Amanda L. Olson, M.D.

Dr. Olson completed Hematology and Oncology fellowship at Memorial Sloan-Kettering in 2013 where her research focus was related to optimization of umbilical cord blood transplantation and infectious complications following hematopoietic stem cell transplant in adults. She currently is an Associate Professor of Medicine in the Department of Stem Cell Transplantation and Cellular Therapy where she oversees clinical research related to cord blood transplantation, mesenchymal stem cell manipulation and cellular therapy.

​Dr. Olson is the Principal Investigator for several cellular therapy trials including a Phase I trial of mesenchymal stem cells transfected with plasmid containing interferon beta for the treatment of refractory epithelial ovarian cancer, an international, multi-institutional, Phase III study evaluating the use of cord blood derived mesenchymal stem cell expansion to expedite hematopoietic engraftment following stem cell transplantation, a Phase I trial of IV mesenchymal stem cells for the use of cardiac regeneration following chemotherapy-induced cardiomyopathy and a Phase II trial of cytotoxic T-lymphocytes in the treatment of BK and JC virus. Dr. Olson has institutional funding and extramural grant support.

---

We wish to thank Dr. Amanda Olson for volunteering her time to speak on
Share the Science and sharing her valuable insight
on monitoring the risks associated with cord blood transplantation.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.